Loading viewer...
earnings
Format: PDF earnings
Illumina reported Q2 2016 revenue of $600 million, up 11% year-over-year, driven by strength in sequencing consumables and microarray products. Non-GAAP EPS of $0.86 exceeded expectations, though operating margin contracted 480 basis points due to increased investments in headcount, GRAIL, and Helix initiatives.
conference
31 Pages
earnings
65 Pages
Range Resources Corporation
Alembic Pharmaceuticals Q3 FY26 Investor Presentation
earningsearnings
20 Pages
Alembic Pharmaceuticals
PSEG Q1 2024 Financial Results Earnings Presentation
earningsearnings
17 Pages
Public Service Enterprise Group